13F Pro Quality Score

45.4/100

Rank #1,717 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

31.3/100

Profitability

30.0/100

Balance Sheet

46.6/100

Earnings Quality

30.0/100

Free Cash Flow

45.1/100

Institutional Flow

57.3/100

Revenue Scale

72.7/100

Dilution Risk

81.8/100

DBD Stock Analysis & AI Quality Score

AI stock analysis and institutional research for DIEBOLD NIXDORF, Inc (DBD), a Technology sector company. 13F Pro's AI-powered ranking engine scores DBD at 45.4/100 on a 32-signal composite quality model, placing it at rank #1,717 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (30.0) and earnings quality (30.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), DIEBOLD NIXDORF, Inc reports quarterly revenue of $891.8M, net income of $5.0M, an operating margin of 3.7%. Top institutional holders of DBD by reported 13-F value include Capital World Investors, Millstreet Capital Management, BlackRock,, based on the most recent SEC filings. DBD trades on the NYSE exchange and files with the SEC under CIK 28823. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DBD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DIEBOLD NIXDORF, Inc directly from SEC EDGAR. DIEBOLD NIXDORF, Inc's 13F Pro composite quality score has ranged between 8 and 62 since 2021, currently 45.4 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Fun facts about DIEBOLD NIXDORF, Inc

Quirks, history, and lore behind DBD — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. technology company · mid-cap · listed on NYSE · headquartered in Ohio.
  • 2
    The Numbers
    Annual revenue in the low billions of dollars, spread across hardware, software, and services — with a debt load that has kept Wall Street sweating for years.
  • 3
    The History
    Its roots go back to the 19th century, and it grew into one of the world's leading makers of cash-handling and self-service machines long before most people knew what a tech company was.
  • 4
    The Secret
    The company is the product of a transatlantic merger between an American safe-and-vault pioneer and a storied German computing firm that once rivaled IBM in Europe.
  • 5
    The Lore
    Its machines guard the money at banks and retailers worldwide, and it has gone through a high-profile bankruptcy restructuring in recent years while still keeping the ATMs humming.
  • 6
    The Giveaway
    If you've ever punched your PIN into an ATM or self-checkout kiosk, there's a good chance this Ohio-born, German-hyphenated company built the box — ticker DBD.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$891.8M

Net Income

Q1 2026

$5.0M

Free Cash Flow

Q1 2026

$31.7M

Operating Margin

Q1 2026

3.7%

ROIC

Q1 2026

1.7%

D/E Ratio

Q1 2026

0.95

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-11.4% YoY
$3.46BFY 2022
FY19 $4.41BFY20 $3.90BFY21 $3.91BFY22 $3.46B

Net Income

-637.8% YoY
$-581.4MFY 2022
FY19 $-341.3MFY20 $-269.1MFY21 $-78.8MFY22 $-581.4M

Operating Income

-254.4% YoY
$-211.7MFY 2022
FY19 $-26.6MFY20 $24.0MFY21 $137.1MFY22 $-211.7M

EPS (Diluted)

-628.7% YoY
$-7.36FY 2022
FY19 FY20 $-3.47FY21 $-1.01FY22 $-7.36

Total Assets

-12.6% YoY
$3.06BFY 2022
FY19 $3.79BFY20 $3.66BFY21 $3.51BFY22 $3.06B

Total Debt

+15.1% YoY
$2.59BFY 2022
FY19 $2.11BFY20 $2.34BFY21 $2.25BFY22 $2.59B

Op. Cash Flow

-414.6% YoY
$-387.9MFY 2022
FY19 $135.8MFY20 $18.0MFY21 $123.3MFY22 $-387.9M

AI Insight: DBD Financial Trends

Revenue volatility persists with Q1 2026 dropping 19% sequentially to $892M despite Q4 2025 hitting $1.1B peak.

Operating income improved from $30M in Q1 2025 to $33M in Q1 2026, though well below Q4 2025's $82M.

Total debt decreased from $1,100M in Q2 2024 to $970M in Q1 2026, reducing leverage.

Operating cash flow turned positive, reaching $32M in Q1 2026 versus negative $8M in Q2 2024.

Quarterly revenue swings remain extreme, ranging from $841M to $1,104M over the past eight quarters.

Equity declined to $1,023M in Q1 2026 from $1,107M in Q3 2025 after recent gains.

AI Insight: DBD Ratio Trends

DBD's profitability collapsed in Q1 2026 with operating margin dropping from 7.5% to 3.7% after strong Q3-Q4 2025 performance.

Operating margin declined sharply from 7.5% in Q4 2025 to 3.7% in Q1 2026, erasing prior quarter gains.

ROIC fell from 15.9% in Q4 2025 to 6.6% in Q1 2026, marking a significant retreat from recent highs.

Net profit margin compressed to 0.6% in Q1 2026 from 4.5% in Q4 2025, indicating profitability pressures.

Debt-to-equity ratio improved from 1.10 in Q2 2024 to 0.95 in Q1 2026, showing gradual deleveraging.

Q1 seasonal weakness appears severe — monitor if this is normal pattern or structural deterioration.

ROIC volatility between 6.1% and 15.9% over recent quarters suggests inconsistent capital efficiency.

Get alerted when DBD's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for DIEBOLD NIXDORF, Inc including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put DBD on your watchlist

Track score changes the day DIEBOLD NIXDORF, Inc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is DBD a good stock to buy?

13F Pro's AI-powered analysis of DIEBOLD NIXDORF, Inc (DBD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for DBD are available on the DBD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own DBD?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling DBD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of DIEBOLD NIXDORF, Inc's investment landscape.